SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jennings JC, Mohan S 1990 Heterogeneity of latent transforming growth factor-β isolated from bone matrix proteins. Endocrinology 126:10141021.
  • 2
    Centrella M, Horowitz MC, Wozney JM, McCarthy TL 1994 Transforming growth factor-β gene family members and bone. Endocr Rev 15:2739.
  • 3
    Rodan GA 1998 Bone homeostasis. Proc Natl Acad Sci USA 95:1336113362.
  • 4
    Beck LS, Amento EP, Xu Y, Deguzman L, Lee WP, Nguyen T, Gillett NA 1993 TGF-β1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-β1. J Bone Miner Res 8:753761.
  • 5
    Joyce ME, Roberts AB, Sporn MB, Bolander ME 1990 Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110:21952207.
  • 6
    Noda M, Camilliere JJ 1989 In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124:29912994.
  • 7
    Rosen D, Miller SC, DeLeon E, Thompson AY, Bentz H, Mathews M, Adams S 1994 Systemic administration of recombinant transforming growth factor β2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15:355359.
  • 8
    Elford PR, Guenther HL, Felix R, Cecchini MG, Fleisch H 1987 Transforming growth factor-β reduces the phenotypic expression of osteoblastic MC3T3-E1 cells in monolayer culture. Bone 8:259262.
  • 9
    Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR 1994 Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, OCN, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855863.
  • 10
    Noda M, Rodan GA 1987 Type β transforming growth factor (TGF β) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J Cell Physiol 133:426437.
  • 11
    Massague J, Chen YG 2000 Controlling TGF-β signaling Genes Dev 14:627644.
  • 12
    Massague J, Wotton D 2000 Transcriptional control by the TGF- β/Smad signaling system. EMBO J 19:17451754.
  • 13
    Li J, Tsuji K, Komori T, Miyazono K, Wrana JL, Ito Y, Nifuji A, Noda M 1998 Smad2 overexpression enhances Smad4 gene expression and suppresses CBFA1 gene expression in osteoblastic osteosarcoma ROS17/2.8 cells and primary rat calvaria cells. J Biol Chem 273:3100931015.
  • 14
    Cheng SL, Lai CF, Blystone SD, Avioli LV 2001 Bone mineralization and osteoblast differentiation are negatively modulated by integrin αVβ3. J Bone Miner Res 16:277288.
  • 15
    Lai CF, Feng X, Nishimura R, Teitelbaum SL, Avioli LV, Ross FP, Cheng SL 2000 Transforming growth factor-β up-regulates the β5 integrin subunit expression via Sp1 and Smad signaling. J Biol Chem 275:3640036406.
  • 16
    Takeshita A, Imai K, Kato S, Kitano S, Hanazawa S 1998 1α,25-dihydroxyvitamin D3 synergism toward transforming growth factor-β1-induced AP-1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor. J Biol Chem 273:1473814744.
  • 17
    Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S 1999 Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:13171321.
  • 18
    Lebrun JJ, Takabe K, Chen Y, Vale W 1999 Roles of pathway-specific and inhibitory Smads in activin receptor signaling. Mol Endocrinol 13:1523.
  • 19
    Hill PA, Tumber A, Meikle MC 1997 Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 138:38493858.
  • 20
    Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 162:156159.
  • 21
    Labarca C, Paigen K 1980 A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344352.
  • 22
    Lowry OH, Roberts NR, Wu M, Hixon WS, Crawford EJ 1954 The quantitative histochemistry of brain. 2. Enzyme measurements. J Biol Chem 207:1937.
  • 23
    Harlow E, Lane D 1988 Antibodies. In: Cell Staining Alkaline Phosphatase-Labeled Reagents. A Laboratory Manual. Cold Spring Harbor Laboratory Press, NY, USA, pp. 406407.
  • 24
    Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC 2000 Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60:60016007.
  • 25
    Takeuchi Y, Fukumoto S, Matsumoto T 1995 Relationship between actions of transforming growth factor (TGF)-β and cell surface expression of its receptors in clonal osteoblastic cells. J Cell Physiol 162:315321.
  • 26
    Peterson WJ, Tachiki KH, Yamaguchi DT 2001 Diminished incorporation of tritiated thymidine into DNA of MC3T3-E1 cells is related to inhibition of thymidine transport cause by extracellular matrix. J Bone Miner Res 16:S1;S492.
  • 27
    Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S 1983 In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191198.
  • 28
    Ibbotson KJ, Orcutt CM, Anglin AM, D'Souza SM 1989 Effects of transforming growth factors β1 and β2 on a mouse clonal, osteoblast-like cell line MC3T3-E1. J Bone Miner Res 4:3745.
  • 29
    Noda M, Rodan GA 1986 Type-β transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun 140:5665.
  • 30
    Takeuchi Y, Suzawa M, Kikuchi T, Nishida E, Fujita T, Matsumoto T 1997 Differentiation and transforming growth factor-β receptor down- regulation by collagen-α2β1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem 272:2930929316.
  • 31
    Lee KL, Aubin JE, Heersche JN 1992 beta-Glycerophosphate-induced mineralization of osteoid does not alter expression of extracellular matrix components in fetal rat calvarial cell cultures. J Bone Miner Res 7:12111219.
  • 32
    Marsh ME, Munne AM, Vogel JJ, Cui Y, Franceschi RT 1995 Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts. J Bone Miner Res 10:16351643.
  • 33
    Montessuit C, Bonjour JP, Caverzasio J 1995 Expression and regulation of Na-dependent P(i) transport in matrix vesicles produced by osteoblast-like cells. J Bone Miner Res 10:625631.
  • 34
    Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH, Millan JL 2000 Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15:18791888.
  • 35
    Whitson SW, Whitson MA, Bowers DE Jr, Falk MC 1992 Factors influencing synthesis and mineralization of bone matrix from fetal bovine bone cells grown in vitro. J Bone Miner Res 7:727741.
  • 36
    Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424442.
  • 37
    Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G 1996 Increased bone formation in OCN-deficient mice. Nature 382:448452.
  • 38
    Engel ME, McDonnell MA, Law BK, Moses HL 1999 Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem 274:3741337420.
  • 39
    Dennler S, Prunier C, Ferrand N, Gauthier JM, Atfi A 2000 Jun inhibits transforming growth factor β-mediated transcription by repressing Smad3 transcriptional activity. J Biol Chem 275:2885828865.
  • 40
    Verrecchia F, Tacheau C, Schorpp-Kistner M, Angel P, Mauviel A 2001 Induction of the AP-1 members c-Jun and JunB by TGF-β/Smad suppresses early Smad-driven gene activation. Oncogene 20:22052211.
  • 41
    Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN 2001 Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling. Proc Natl Acad Sci USA 98:38373842.
  • 42
    Borton AJ, Frederick JP, Datto MB, Wang XF, Weinstein RS 2001 The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res 16:17541764.
  • 43
    Alliston T, Choy L, Ducy P, Karsenty G, Derynck R 2001 TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and OCN expression and inhibits osteoblast differentiation EMBO J 20:22542272.